Gilead Sciences on Track for Highest Close Since April — Data Talk
Gilead Sciences, Inc. (GILD) is currently at $71.64, up $3.15 or 4.59%
--Would be highest close since April 2, 2024, when it closed at $72.09
--Currently up two consecutive days; up 13.44% over this period
--Best two day stretch since the two days ending March 18, 2020, when it rose 15.27%
--Up 11.46% month-to-date
--Down 11.57% year-to-date
--Down 41.38% from its all-time closing high of $122.21 on June 23, 2015
--Down 7.53% from 52 weeks ago (June 23, 2023), when it closed at $77.47
--Down 17.93% from its 52-week closing high of $87.29 on Jan. 19, 2024
--Up 13.44% from its 52-week closing low of $63.15 on June 18, 2024
--Traded as high as $72.18; highest intraday level since April 2, 2024, when it hit $72.85
--Up 5.39% at today's intraday high
--Best performer in the S&P 500 today
--
--Best performer in the Nasdaq 100 today
All data as of 9:48:54 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 21, 2024 10:07 ET (14:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations